Previous Article | Next Article 
Journal of Virology, April 2003, p. 4960-4964, Vol. 77, No. 8
0022-538X/03/$08.00+0 DOI: 10.1128/JVI.77.8.4960-4964.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Adenovirus Dodecahedron Allows Large Multimeric Protein Transduction in Human Cells
P. Fender,1* G. Schoehn,1,2 J. Foucaud-Gamen,3 E. Gout,1 A. Garcel,1 E. Drouet,3 and J. Chroboczek1
Institut de Biologie Structurale,1
Laboratoire Européen de Biologie Moléculaire, 38027 Grenoble,2
Faculté de Pharmacie, Domaine de la Merci, 38 La Tronche, France3
Received 11 November 2002/
Accepted 14 January 2003

ABSTRACT
Adenovirus dodecahedron is a virus-like particle composed of
only two viral proteins of human adenovirus serotype 3 that
are responsible for virus attachment and internalization. We
show here that this dodecameric particle, devoid of genetic
information, efficiently penetrates human cells and can deliver
large multimeric proteins such as immunoglobulins.

TEXT
Human adenoviruses (Ads) are nonenveloped viruses responsible
for respiratory, ocular, and enteric infections. Their icosahedral
capsid, containing the 36-kpb double-stranded DNA genome, is
composed of three major proteins: the hexon, the penton (Pt)
base, and the fiber. At the 12 vertices of the capsid, the protruding
fiber is noncovalently attached to the Pt base, thus forming
the Pt complex. It has been reported that the fiber interacts
with a high affinity with a primary receptor and that the subsequent
interaction of the Pt base RGD motif with cellular integrins
triggers endocytosis (
17). A 42-kDa protein, called the coxsackievirus
and Ad receptor (CAR), is recognized by at least one serotype
of each of the six subgroups of Ad except for the serotypes
belonging to subgroup B (i.e., Ad3) (
1,
12). Even though that
Ad capsid is composed of at least 11 proteins, it has been shown
that Pt alone can penetrate into human cell lines, thus making
of this complex a potential vector for DNA delivery (
2,
5,
7,
8,
16). Remarkably, Ad3 but not Ad5 Pt expressed in the baculovirus
system led to the formation of symmetric complexes of 12 Pts
called dodecahedron (Dd). We have previously shown that the
non-CAR-binding Ad3-Dd can be used as a gene transfer vector
(
2), and we show here that this virus-like particle is also
able to transduce large multimeric proteins into human cells.
Dd internalization.
Coexpression of Ad3 Pt base and fiber proteins in the baculovirus system led to the formation of a symmetric dodecameric particle (2, 14), Pt-Dd (Fig. 1a). This complex results from the interaction between the pentameric base proteins, as attested by the Dd formation upon expression of base proteins alone (Bs-Dd; Fig. 1a). The respective roles of the fiber and the Pt base protein in Ad3 Dd entry into HeLa cells was assessed by immunofluorescence. HeLa cells grown in a 96-multiwell plate (Falcon) at 2 x 104 cells per well were incubated in 100 µl of phosphate-buffered saline (PBS) with a range of Dd concentrations. After 1 h at 37°C, cells were permeabilized, and the amount of Dd present in the cells was estimated by using a rabbit polyclonal serum recognizing the Ad3 Pt base, followed by incubation with a goat anti-rabbit secondary fluorescein isothiocyanate (FITC)-labeled antibody (Santa Cruz). After PBS washes, fluorescence quantification was performed by using a plate reader fluorimeter (485 and 535 nm; Wallac). The antibody background was subtracted, and the mean of three measurements is shown in Fig. 1b. The Bs-Dd was capable of entering human cells, suggesting that a direct interaction between the RGD motifs of the Pt base and the cellular integrins or between the Pt base and another cellular component (5) is sufficient for cell entry. However, the presence of fiber in the Pt-Dd dramatically increased the level of Dd entry, suggesting a more efficient two-step endocytosis mediated by this protein.
MAb production and characterization.
Monoclonal antibodies (MAbs) have been produced against ion-exchange
chromatography-purified Bs-Dd according to the classical protocol
(
6). Two retained hybridomas were analyzed by Western blot and
enzyme-linked immunosorbent assay (ELISA). The 5C12 hybridoma
recognized both Bs-Dd and Pt-Dd only in their native forms (as
determined by ELISA), indicating that the recognized epitopes
are exposed on the Dd surface and that the presence of the fiber
does not interfere with MAbs binding to the base protein. In
contrast, the 5F5 clone, which was strongly reactive toward
the sodium dodecyl sulfate-denatured base protein (detection
of 0.1 ng of denaturated base in a Western blot), recognized
only weakly the native Dd by ELISA.
Electron microscopy study of Bs-Dd-5C12 complex.
MAb-Dd complexes were obtained by incubation of purified Dds with purified MAbs. After sucrose gradient (15 to 40%) density centrifugation (4 h at 200,000 x g in a TLS55 rotor [Beckman]), 5C12 MAb was found at the bottom of the tube, together with Dd, whereas the 5F5 MAb that is unable to strongly bind native Dd remained in the upper part of the gradient (data not shown). An aliquot of purified Bs-Dd-5C12 complex was applied to the carbon on mica and negatively stained with 1% silicotungstate (pH 7.0) for electron microscopy (Fig. 2). Micrographs were obtained under low-dose conditions by using a JEOL 1200 EX II microscope at 100 kV and a nominal magnification of x40,000. The fuzzy outline and the increased size of Bs-Dd-5C12 versus Bs-Dd alone suggest that the particle is decorated by immunoglobulin G.
MAb entry into HeLa cells with Dd as a vector.
In order to find out whether MAbs can be delivered to the cell
by Dd, Dd-MAb complexes (0.6 nM with respect to Dd) were incubated
for different times with living HeLa cells in a 96-multiwell
plate (Falcon) at 2
x 10
4 cells per well. After methanol permeabilization,
the level of MAb entry was determined by using a fluorescent
secondary antibody directed against the mouse monoclonal antibody.
After PBS washes, fluorescence quantification was performed
by using a plate reader fluorimeter (485 and 535 nm; Wallac).
The antibody background was subtracted, and the mean of three
measurements is shown in Fig.
3a. Bs-Dd permitted a limited
transduction of 5C12 MAbs with a maximum level obtained at 90
min, whereas Pt-Dd permitted a very efficient transduction of
5C12 MAbs, with a maximum reached after 20 min only. These results
show that the fiber in Pt-Dd improved considerably the protein
transduction efficiency and also reduced the time needed by
the Pt-Dd-MAb complex to bind and enter the cells.
The approximate amount of MAbs and Pt-Dd present inside the
HeLa cell was determined by Western blot analysis. HeLa cells
grown in a 96-multiwell plate (Falcon) at 2
x 10
4 cells per
well were transduced for 1 h at 37°C with either 0.6 nM
concentrations of Bs-Dd-5C12 or Pt-Dd-5C12 complexes or with
5C12 alone. After washes with PBS, cells were lysed in 100 µl
of cell lysis buffer (Promega), and 10-µl aliquots were
boiled and subjected to sodium dodecyl sulfate-polyacrylamide
gel electrophoresis, together with known amounts of either purified
Pt-Dd or 5C12 MAb. After transfer to a polyvinylidene difluoride
membrane, the blot was treated with either anti-mouse horseradish
peroxidase (HRP) antibody (visualization of transduced 5C12)
or anti-Pt base antibody and anti-rabbit HRP antibody (visualization
of internalized Dd). Estimation of Dd and 5C12 present inside
the cell was performed by band scanning (Molecular Analyst;
Bio-Rad), and the results were scaled to the number of cells
per well (Fig.
3b). About 6 ng of Pt-Dd and 3 ng of 5C12 MAbs
were found in 2
x 10
4 HeLa cells, representing an average of
5
x 10
4 Pt-Dd and 5.7
x 10
5 MAbs per cell. This result indicates
an average ratio of about 12 MAbs per Dd, suggesting a stoichiometric
process of MAb attachment to Dd. This experiment shows an efficient
and stable interaction of 5C12 MAb with Dd, as well as very
efficient cell transduction of attached MAbs. As expected, the
amount of Bs-Dd was much lower than that of Pt-Dd. Since we
determined by ELISA that equivalent amounts of 5C12 MAb were
bound to Bs-Dd and Pt-Dd (data not shown), the 10-fold-smaller
amount of antibody transduced by Bs-Dd is consistent with the
lower penetration efficiency of this particle (Fig.
3).
MAb localization upon transduction.
MAb localization in transduced cells was monitored by confocal microscopy. About 105 HeLa cells were incubated for different periods of time with a 0.6 nM concentration of the Pt-Dd-5C12 complex. After a given period of entry, cells were washed and permeabilized and 5C12 MAb was detected by using an FITC-labeled secondary antibody (Fig. 4). Laser scanning confocal microscopy was performed on an MRC600 (Bio-Rad). Incubation times as short as 5 min were sufficient to detect some Pt-Dd-5C12 complexes bound to the plasma membrane and, after 10 min of incubation, a green signal surrounding the cells was observed. Consistent with the kinetic experiment (Fig. 3a), complex internalization began after 20 min (Fig. 4D). After 1 h of incubation, MAbs were detected close to the nucleus, whereas a control experiment performed with 5C12 antibody without Dd gave no signal, thus attesting that MAbs delivery into the cells is mediated by the Pt-Dd (Fig. 4E and A, respectively). Moreover, incubation of Dd with the 5F5 MAb (which was unable to recognize native Dd) on a HeLa cell produced no signal as in Fig. 4A, thus confirming that protein delivery occurs only when the MAb is attached to Dd. A similar experiment of confocal microscopy done with Bs-Dd-5C12 complexes confirmed the weaker and delayed transduction of 5C12 in HeLa cells observed in Fig. 3a (data not shown).
Activity of the transduced protein.
It has been reported that the cell entry of subgroup B Ads (i.e.,
Ad3 and Ad7) is different from that of the subgroup C Ads (i.e.,
Ad2 and Ad5). The major difference lies in the ability of subgroup
C Ads to escape endosomes, whereas subgroup B Ads accumulate
in late endosomes and to a small extent in lysosomes prior to
their cytosol escape (
9,
10). It was therefore important to
assess whether the activity of the transduced protein is retained
during the trafficking process. For this, we developed an enzyme
delivery system. Purified Pt-Dd and Bs-Dd were biotinylated
with 1 mM Sulfo-NHS-LC-LC-biotin (Pierce). After removal of
the unbound biotin, a 0.6 nM concentration of biotinylated Bs-Dd
or Pt-Dd was incubated for 30 min in PBS with a 0 to 15 nM concentration
of streptavidin conjugated to HRP (SptAv-HRP; Jackson Laboratories).
HeLa cells grown in a 96-multiwell plate (2
x 10
4 cells per
well) were then incubated with the complexes and, after 1 h
at 37°C, the cells were lysed in 100 µl of cell lysis
buffer (Promega). The enzyme activity was determined by photometry
at 492 nm after the addition of 100 µl of the colorimetric
peroxidase substrate
o-phenylenediamine (3 mg/ml; Sigma). Nonbiotinylated
Dd incubated with 0 to 15 nM of StpAv-HRP was used for background
substraction. The experiment was performed in triplicate, and
the results are expressed as the mean of the values (Fig.
5).
This experiment shows an exogenous peroxidase activity in cells
incubated with biotinylated Dd-StpAv-HRP, thus demonstrating
that enzyme was delivered by biotinylated Dd and that at least
a part of the transduced proteins remained active 1 h after
transduction. During biotinylation of Pt-Dd, fiber protein is
also biotinylated which could, in part, neutralize its function,
and it can possibly explain the two- to threefold difference
in transduction efficiency of Pt-Dd and Bs-Dd in this experiment
compared to the 10-fold difference observed with MAb delivery
(Fig.
3).
MAb delivery into human cells by Dd shows that this particle
can act as a protein transduction vector. Protein transduction
technology represents an alternative to gene transfer technology
when no gene insertion into genome is required (
3,
11,
15).
This technology may be appropriate for restricted applications;
it is also potentially a basis for an entirely new form of therapy
and may allow us to overcome some of the technical hurdles of
gene therapy. Protein transduction could be useful for the efficient
antigen loading of dendritric cells for a range of vaccination
purposes, including anti-tumor immune therapy. Interestingly,
both Dd and the Ad virion contain 12 Pts and efficiently enter
human cells. However, contrary to the complete Ad capsid, the
Dds are compact particles devoid of any viral DNA. Consequently,
Ad Dd might be a safe alternative vector to use instead of the
whole Ad. In order to deliver proteins other than MAbs into
the cells by Dd, a strategy aiming to fuse the protein of interest
to a single-chain antibody derived from 5C12 can be considered.
Moreover, it has been recently observed that the two PPxY motifs
present in the Ad Pt base sequence interacted with WW domains
of several proteins (
4). As reported for polyomavirus-like particle,
in which the WW domain has been inserted in order to target
PPxY motif (
13), we can hypothesize that the fusion of therapeutic
protein to WW domains might permit its attachment to the Dd,
thus allowing its transduction into the target cell.

ACKNOWLEDGMENTS
We thank R. Ruigrok for discussions and advice with the electron
microscopy study and R. H. Wade for help with the manuscript.
This work was supported in part by grant EMERGENCE 2001-Région Rhône Alpes.

FOOTNOTES
* Corresponding author. Mailing address: Institut de Biologie Structurale, 41 Rue Jules Horowitz, 38027 Grenoble, France. Phone: 33-4-38-78-96-28. Fax: 33-4-38-78-54-94. E-mail:
fender{at}ibs.fr.


REFERENCES
1 - Bergelson, J. M., J. A. Cunningham, G. Droguett, E. A. Kurt-Jones, A. Krithivas, J. S. Hong, M. S. Horwitz, R. L. Crowell, and R. W. Finberg. 1997. Protein structure and isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5. Science 275:1320-1323.
2 - Fender, P., R. W. Ruigrok, E. Gout, S. Buffet, and J. Chroboczek. 1997. Adenovirus dodecahedron, a new vector for human gene transfer. Nat. Biotechnol. 15:52-56.[CrossRef][Medline]
3 - Ford, K. G., B. E. Souberbielle, D. Darling, and F. Farzaneh. 2001. Protein transduction: an alternative to genetic intervention? Gene Ther. 8:1-4.[CrossRef][Medline]
4 - Galinier, R., E. Gout, H. Lortat-Jacob, J. Wood, and Chroboczek, J. 2002. Adenovirus protein involved in virus internalization recruits ubiquitin-protein ligases. Biochemistry 41:14299-14305.[CrossRef][Medline]
5 - Hong, S. S., B. Gay, L. Karayan, M. C. Dabauvalle, and P. Boulanger. 1999. Cellular uptake and nuclear delivery of recombinant adenovirus penton base. Virology 262:163-177.[CrossRef][Medline]
6 - Kohler, G., and C. Milstein. 1975. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256:495-497.[CrossRef][Medline]
7 - Medina-Kauwe, L. K., N. Kasahara, and L. Kedes. 2001. 3PO, a novel nonviral gene delivery system using engineered Ad5 penton proteins. Gene Ther. 8:795-803.[CrossRef][Medline]
8 - Medina-Kauwe, L. K., M. Maguire, N. Kasahara, and L. Kedes. 2001. Nonviral gene delivery to human breast cancer cells by targeted Ad5 penton proteins. Gene Ther. 8:1753-1761.[CrossRef][Medline]
9 - Miyazawa, N., P. L. Leopold, N. R. Hackett, B. Ferris, S. Worgall, E. Falck-Pedersen, and R. G. Crystal. 1999. Fiber swap between adenovirus subgroups B and C alters intracellular trafficking of adenovirus gene transfer vectors. J. Virol. 73:6056-6065.[Abstract/Free Full Text]
10 - Miyazawa, N., R. G. Crystal, and P. L. Leopold. 2001. Adenovirus serotype 7 retention in a late endosomal compartment prior to cytosol escape is modulated by fiber protein. J. Virol. 75:1387-1400.
11 - Morris, M. C., J. Depollier, J. Mery, F. Heitz, and G. Divita. 2001. A peptide carrier for the delivery of biologically active proteins into mammalian cells. Nat. Biotechnol. 19:1173-1176.[CrossRef][Medline]
12 - Roelvink, P. W., A. Lizonova, J. G. Lee, Y. Li, J. M. Bergelson, R. W. Finberg, D. E. Brough, I. Kovesdi, and T. J. Wickham. 1998. The coxsackievirus-adenovirus receptor protein can function as a cellular attachment protein for adenovirus serotypes from subgroups A, C, D, E, and F. J. Virol. 72:7909-7915.[Abstract/Free Full Text]
13 - Schmidt, U., R. Rudolph, and G. Böhm. 2001. Binding of external ligands onto an engineered virus capsid. Protein Eng. 14:769-774.[Abstract/Free Full Text]
14 - Schoehn, G., P. Fender, J. Chroboczek, and E. A. Hewat. 1996. Adenovirus 3 penton dodecahedron exhibits structural changes of the base on fibre binding. EMBO J. 15:6841-6846.[Medline]
15 - Schwartz, J. J., and S. Zhang. 2000. Peptide-mediated cellular delivery. Curr. Opin. Mol. Ther. 2:162-167.[Medline]
16 - Smith, C. C., M. Kulka, and L. Aurelian. 2000. Modified adenovirus penton base protein (UTARVE) as a non-replicating vector for delivery of antisense oligonucleotides with antiviral and/or antineoplastic activity. Int. J. Oncol. 17:841-850.[Medline]
17 - Wickham, T. J., P. Mathias, D. A. Cheresh, and G. R. Nemerow. 1993. Integrins
vß3 and ßvß5 promote adenovirus internalization but not virus attachment. Cell 73:309-319.[CrossRef][Medline]
Journal of Virology, April 2003, p. 4960-4964, Vol. 77, No. 8
0022-538X/03/$08.00+0 DOI: 10.1128/JVI.77.8.4960-4964.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Fuschiotti, P., Fender, P., Schoehn, G., Conway, J. F.
(2006). Development of the dodecahedral penton particle from adenovirus 3 for therapeutic application.. J. Gen. Virol.
87: 2901-2905
[Abstract]
[Full Text]